Sutro Biopharma, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
STRO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
111 Oyster Point Blvd., South San Francisco, California

Insiders trading volume in the past year

Sutro Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William J. Newell CEO, Director $2.37M Mar 5, 2024
Hans-Peter Gerber Chief Scientific Officer $910K Mar 5, 2024
Anne Borgman Chief Medical Officer $885K Mar 5, 2024
Edward C. Albini Cfo And Secretary $840K Mar 5, 2024
Jane Chung President And Coo $699K Aug 9, 2024
Trevor Hallam Pres. Rsrch & Cf. Sctific Ofcr $508K Apr 14, 2023
Linda A. Fitzpatrick Chief People & Comm. Officer $493K Mar 5, 2024
Barbara Leyman Chief Business Dev. Officer $374K Jul 8, 2024
Arturo Molina Chief Medical Officer $354K Mar 4, 2022
Shabbir Anik Chief Technical Ops. Officer $274K Mar 3, 2023
Venkatesh Srinivasan Chief Tech Op Officer $268K May 1, 2024
Daniel H. Petree Director $106K Jun 6, 2024
Nicki Vasquez Chief Port. Strat & Alnce Ofcr $71.3K -$60.9K -46.1% Jan 29, 2024
Brunilda Shtylla Chief Business Officer Aug 28, 2023
James P. Panek Director Jun 6, 2024
Heidi Hunter Director Jun 6, 2024
Joseph M. Lobacki Director Jun 6, 2024
John G. Freund Director Jun 6, 2024
Shalini Sharp Director Jun 6, 2022
Jon Marc Wigginton Director Jun 6, 2024
Michael Dybbs Director Jun 6, 2024
Sukhi Jagpal Director Aug 8, 2024
Connie Matsui Director Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for Sutro Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.